ZA938844B - Injectable composition. - Google Patents

Injectable composition.

Info

Publication number
ZA938844B
ZA938844B ZA938844A ZA938844A ZA938844B ZA 938844 B ZA938844 B ZA 938844B ZA 938844 A ZA938844 A ZA 938844A ZA 938844 A ZA938844 A ZA 938844A ZA 938844 B ZA938844 B ZA 938844B
Authority
ZA
South Africa
Prior art keywords
injectable composition
injectable
composition
Prior art date
Application number
ZA938844A
Inventor
David Carver
Timothy R Prout
Hernita Ewald
Original Assignee
Napro Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napro Biotherapeutics Inc filed Critical Napro Biotherapeutics Inc
Publication of ZA938844B publication Critical patent/ZA938844B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
ZA938844A 1992-11-27 1993-11-26 Injectable composition. ZA938844B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL607492 1992-11-27

Publications (1)

Publication Number Publication Date
ZA938844B true ZA938844B (en) 1994-08-02

Family

ID=3776561

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938844A ZA938844B (en) 1992-11-27 1993-11-26 Injectable composition.

Country Status (8)

Country Link
KR (1) KR100371062B1 (en)
CN (2) CN1096673A (en)
AU (1) AU5553894A (en)
IL (2) IL107776A0 (en)
IN (1) IN176188B (en)
NZ (1) NZ258044A (en)
WO (1) WO1994012198A1 (en)
ZA (1) ZA938844B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835657B1 (en) * 1992-11-27 2004-08-25 Mayne Pharma (USA) Inc. Stable injectable paclitaxel composition
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
FR2710534B1 (en) * 1994-09-28 1996-07-05 Bristol Myers Squibb Co Stabilization solvent, pharmaceutical composition containing it, and process for its preparation.
NL9500340A (en) * 1995-02-22 1996-10-01 Yew Tree Pharmaceuticals B V Stabilized paclitaxel solution and pharmaceutical preparation containing said solution
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
DE19536165A1 (en) * 1995-09-28 1997-04-03 Basf Ag Process for cleaning alkoxylated fats
CA2240595A1 (en) * 1995-12-21 1997-07-03 Bijan Almassian Taxane composition and method
KR100191446B1 (en) * 1996-05-02 1999-06-15 송영욱 Agent cotaining paclitaxel for the treatment of system lupous erythematosus
KR100330373B1 (en) * 1996-05-28 2002-11-07 주식회사한국신약 Pharmaceutical composition for injection containing taxol
KR100358934B1 (en) * 1996-09-13 2003-01-29 주식회사한국신약 Pharmaceutical composition of injection containing taxol for
US6045808A (en) * 1997-01-31 2000-04-04 Pharmacia & Upjohn Company Method for removing high boiling solvents from drug formulations by vacuum drying
ATE226070T1 (en) * 1997-05-30 2002-11-15 Man Woo Han PHARMACEUTICAL SOLUTION FOR INJECTION CONTAINING TAXOL
CN1101677C (en) * 1997-05-30 2003-02-19 韩万愚 Pharmaceutical injection solution containing taxol
BE1011216A3 (en) * 1997-06-13 1999-06-01 Thissen En Abrege L T B Lab Pharmaceutical form for the administration of paclitaxel, method of preparation of a composition paclitaxel ready to employment and use thereof.
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
JP2004536026A (en) 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． Pharmaceutical formulations containing paclitaxel, its derivatives, and pharmaceutically acceptable salts
DE10115740A1 (en) * 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
KR100774366B1 (en) * 2001-09-10 2007-11-08 주식회사 중외제약 Injectable composition of paclitaxel
CZ294371B6 (en) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilized pharmaceutical composition based on polyoxyethylated castor oil and process for preparing thereof
PT2286795T (en) * 2002-06-26 2017-01-27 Syncore Biotechnology Co Ltd Method of producing a cationic liposomal preparation comprising a lipophilic compound
KR20080030024A (en) * 2005-06-17 2008-04-03 호스피라 오스트레일리아 피티와이 리미티드 Liquid pharmaceutical formulations of docetaxel
DK3311805T3 (en) 2005-08-31 2020-04-14 Abraxis Bioscience Llc COMPOSITIONS CONTAINING VERY WATER-SOLUBLE PHARMACEUTICAL AND ANTIMICROBIAL AGENTS
CN101396354B (en) * 2007-09-30 2010-12-01 江苏恒瑞医药股份有限公司 Stable taxabe compound liquid combination and preparation method and use thereof
CN101829051B (en) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1'-acetoxychavicol acetate injection
CN103432109B (en) * 2013-09-01 2015-09-23 吴静 The pharmaceutical composition of paclitaxel
US10561766B2 (en) * 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
TW223634B (en) * 1991-03-18 1994-05-11 Kingston David G I
AU1888792A (en) * 1991-04-19 1992-11-17 University Of Mississippi, The Methods and compositions for isolating taxanes

Also Published As

Publication number Publication date
IN176188B (en) 1996-02-24
AU5196793A (en) 1994-06-09
IL126178A0 (en) 1999-05-09
AU667142B2 (en) 1996-03-07
IL107776A0 (en) 1994-02-27
CN1047305C (en) 1999-12-15
CN1095266A (en) 1994-11-23
AU5553894A (en) 1994-06-22
NZ258044A (en) 1995-12-21
WO1994012198A1 (en) 1994-06-09
CN1096673A (en) 1994-12-28
KR100371062B1 (en) 2003-04-21

Similar Documents

Publication Publication Date Title
EP0598412A3 (en) Skinprotection composition.
ZA938844B (en) Injectable composition.
ZA939656B (en) Microvicidal compositions.
EP0621279A3 (en) Siloxy-aluminoxane compositions.
EP0597463A3 (en) Thermotherapiesonde.
EP0573056A3 (en) Positive resist composition.
EP0580285A3 (en) Auto-reclosers.
EP0671929A4 (en) Compositions.
IL106891A (en) ENR-NR composition
GB2268499B (en) Chipping-resistant composition
EP0600195A3 (en) Rubber composition.
EP0572808A3 (en) Antiblocage-system.
EP0570884A3 (en) Positive resist composition.
EP0571988A3 (en) Positive resist composition.
PH30973A (en) Stabilized hypohalite composition.
PH31578A (en) Peroxygene bleach composition.
EP0668864A4 (en) Substituted biphenylmethylimidazopyridines.
PH30815A (en) Composition.
EP0571989A3 (en) Positive resist composition.
EP0599191A3 (en) Speed-governor-circuit.
GB9223133D0 (en) Composition
CY2411B1 (en) Compositions.
EP0598320A3 (en) Positive resist composition.
EP0592354A3 (en) Vacuum-centrifuge.
GB2272222B (en) Command-curable composition